Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2005
12/14/2005EP1121355B1 Quinoline derivatives and their use as antibacterial agents
12/14/2005EP1119562B1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005CN1708497A 8-substituted imidazopyridines
12/14/2005CN1708493A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1708492A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1708306A Quinazolinone compounds as calcilytics
12/14/2005CN1706842A Synthesis process of 1,7-disubstituent-3,4:9,10-perylene bisimide
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/13/2005US6974873 Preferential compound for use as diagnostic tool
12/13/2005US6974869 Piperizinones as modulators of chemokine receptor activity
12/13/2005US6974822 Treating osteoarthritis or rheumatoid arthritis
12/13/2005US6974815 effective as antagonists of Leukointegrins and/or ICAMs
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/08/2005WO2005116034A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005WO2005116030A1 A process for the preparation of tadalafil
12/08/2005WO2005116029A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005WO2005116028A2 Bicyclic heterocycles as kinase inhibitors
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115972A1 Therapeutic compounds
12/08/2005WO2005115399A2 Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005085196A3 Inhibitors of dna methylation in tumor cells
12/08/2005WO2005068464A3 Process for preparing tadalafil and its intermediates
12/08/2005WO2005055951A3 Methods and compositions for slowing aging
12/08/2005WO2005040111A3 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acids
12/08/2005WO2005018555A3 Lipid-modified immune response modifiers
12/08/2005WO2004099126A8 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004096139A8 Aza spiro alkane derivatives as inhibitors of metalloproteases
12/08/2005WO2004078682A3 Cyclic compounds and compositions as protein kinase inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272799 Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272765 Dipeptidyl peptidase inhibitors
12/08/2005US20050272764 Imidazopyridine compound
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272760 Use of pyridoindolone derivatives for the preparation of medicinal products
12/08/2005US20050272759 Administering 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; angiogenesis inhibitors; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration
12/08/2005US20050272757 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
12/08/2005US20050272756 Pyridopyrrolizine and pyridoindolizine derivatives
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272751 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272735 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/08/2005US20050272666 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/08/2005DE4213005B4 Verwendung von Aromatasehemmern zur Empfängnisverhütung bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus Use of aromatase inhibitors for contraception in female primates without affecting the menstrual cycle
12/08/2005DE102004022897A1 Azinyl-imidazoazine Azinyl-imidazoazines
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568056A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/08/2005CA2565486A1 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005CA2565066A1 Therapeutic compounds
12/08/2005CA2564884A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/07/2005EP1601676A2 Fused imidazoles as transforming growth factor (tgf) inhibitors
12/07/2005EP1601674A2 Hydroxy alkyl substituted 1,3,8-triazaspiro 4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1601672A1 Triazolo-pyridines as anti-inflammatory compounds
12/07/2005EP1499607B1 4-(piperidyl- and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
12/07/2005EP1467984A4 Synthesis of 4,5-dihydro-pyrazolo (3,4-c) pyrid-2-ones
12/07/2005EP1450800A4 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1073657B1 Imidazo pyridine derivatives which inhibit gastric acid secretion
12/07/2005CN1705672A New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
12/07/2005CN1705667A New fused pyrrolo-carbazole or pyrido-pyrrolo-indole derivatives (i), useful for treating cancer
12/07/2005CN1705666A White organic fluorescent compound
12/07/2005CN1705665A 7-phenylpyrazolopyridine compounds
12/07/2005CN1705661A Method for preparing risperidone
12/07/2005CN1705468A Nuclear hormone receptor compounds, products and methods employing same
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/06/2005US6972334 Bathophenathroline compound and process for preparing same
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972293 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/06/2005CA2254557C Synthesis of long-wavelength absorbing photosensitizers
12/04/2005CA2568914A1 Therapeutic agents, and methods of making and using the same
12/03/2005CA2529613A1 Agent for repairing corneal sensitivity containing amide compound
12/01/2005WO2005113562A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005WO2005113553A2 Azinyl imidazoazine and azinyl carboxamide
12/01/2005WO2005113552A1 Substituted azachinazolines having an antiviral action
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113513A2 Aryl sulfonamides
12/01/2005WO2005113505A1 Method for the production of a-chloroalkylpyridyl ketones and/or the hydrochlorides thereof
12/01/2005WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer